Navigation Links
Cardium Presents Year-End 2012 Financial Results And Recent Developments
Date:4/5/2013

s of To Go Brands, Inc.  Other trademarks belong to their respective owners.

 Cardium Therapeutics, Inc.Selected Condensed Consolidated Results of OperationsThree months ended December 31,The year ended December 31,2012201120122011Product sales$
746,077$
-$
785,318$
-Cost of goods sold(421,874)-(437,065)-Gross profit324,203-348,253-Operating expensesResearch and development(523,646)(718,845)(2,621,321)(2,593,258)Selling, general and administrative(1,758,040)(1,183,039)(6,116,746)(4,824,659)Loss from operations(1,957,483)(1,901,884)(8,389,814)(7,417,917)Interest income (expense), net(1,424)782,3475,683Change in fair value of derivative liabilities-(175,057)64,157283,142Net loss $   (1,958,907)$  (2,076,863)$(8,323,310)$ (7,129,092)Net loss per common  share – basic and diluted$
(0.02)$
(0.02)$
(0.07)$
(0.08)Weighted average common shares outstanding  – basic and diluted127,267,49190,908,169118,454,33985,066,566 Selected Condensed Consolidated Balance Sheet DataDecember 31,  

2012December 31,

2011Cash and cash equivalents$
2,328,074$
4,721,279Restricted cash50,000200,000Accounts receivable328,953-Inventory1,174,323434,130Prepaid expenses and other current assets407,38968,204Property and equipment, net97,582135,581Intangible assets2,803,7211,332,727Other long-term assets619,836611,308Total assets$
7,808,878$
7,503,229Accounts payable and accrued liabilities$
,392,718$
,214,480Derivative liabilities-85,506Long-term liabilities50,370118,313Total liabilities1,443,0881,418,299Stockholder's equity 6,365,7906,084,930Total liabilities and stockholder's equity$
7,808,878$
7,503,299 


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
2. Cardium Receives ISO Certification for Excellagen
3. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
4. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
5. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
6. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
7. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
8. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
11. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... NORTH WALES, Pa., Aug. 18 AirPal ®, ... and positioning technology, has announced the expansion of its ... positioning functionality. "This announcement marks the launch ... Positioning™ systems," said Jim Weedling, President AirPal, Inc.  "Among ...
... LAUDERDALE, Fla., Aug. 18 After a lengthy ... of power mobility products and services, has selected ... to help strengthen and broaden the company,s brand ... Advertising and Daggerwing, Omnicom,s team will include Javelin ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2Omnicom Adds National Healthcare Giant to Client Roster 2Omnicom Adds National Healthcare Giant to Client Roster 3
(Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities have ... Now, TheCelebrityDresses.com is offering great discounts on all ... The company aims to help ladies from all ... on valuable, trendy formal outfits. , TheCelebrityDresses.com is ... occasion dresses. Their dresses are popular among both ...
(Date:5/26/2015)... U.S. Food and Drug Administration (FDA) regulations ... extensive and can be difficult to understand. Registrar ... companies comply with FDA regulations, compiled a list of ... requirements. , 1. Start researching early. Marketing ... a lengthy process depending on the classification of the ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his fellow board ... have launched a Balloon Sinuplasty website to inform potential ... the benefits of Balloon Sinuplasty. , The website includes ... someone is a good candidate for Balloon Sinuplasty. The ... can contribute to chronic nasal congestion. If the user ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 The ... Hooker as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in dentistry. NAPW is ... boasting more than 700,000 members and over 200 operating ... into this exceptional group of professional women,” said NAPW ...
(Date:5/25/2015)... 25, 2015 World Patent Marketing, a ... the Hidee-Hose, an undergarment patent that allays women’s fears ... Women's Hosiery industry forecasts the market to reach $20.3 ... Creative Director of World Patent Marketing , "The ... ahead and is expected to maintain its lead. The ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3
... such as broccoli, Brussel sprouts, cauliflower and green cabbage ... of cancer . But, researchers have now warned that ... properties. ,Brassica vegetables have a high concentration ... cancer preventive substances known as isothiocyanates. ...
... heed of, by bosses. The study shows that feelings of ... consequences, like a heart attack. ,The study ... published in the Journal of Epidemiology and Community Health tracked ... for almost 11 years. ,The researchers found that ...
... percent of U.S. adults may have some form of ... about 2.4 percent with a "sub-threshold" condition, according ... General Psychiatry. ,Individuals with bipolar disorder tend ... characterized by impulsive behavior and an increased activity leveland ...
... American research, the most effective weight-loss diet for any person ... author David Ludwig, director of the Optimal Weight for Life ... shows that one diet doesn't necessarily fit all', also notes ... their weight in their midsection lost a lot more ...
... scientists at the Georgia Institute of Technology and the Ovarian ... to be essential in helping chemotherapy kill cancer cells, may ... 70 percent of subjects whose tumors had mutations in the ... normal p53 displayed only a 30 percent survival rate. ...
... new study has shown that cigarette smoking is more strongly ... ,The study, published in the Journal of ... and neck cancers among non-drinkers was due to smoking. ... Agency for Cancer Research in Lyon, the researchers examined head ...
Cached Medicine News:Health News:Boiling Makes Broccoli to Loses Its Anticancer Properties 2Health News:Feelings Of Injustice At Work Can Lead To A Heart Attack 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 3Health News:Check Your Physiology Before You Choose A Diet 2Health News:Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive 2
Sphenoidal electrodes provide a less invasive method of recording brain activity in the epilepsy patient. Like all Integra Epilepsy electrodes, sphenoidal electrodes are fabricated from implant-grade...
... in collaboration with Dr. George Ojemann ... Ojemann Cortical Stimulator is the industry ... This portable, constant current unit has ... suitable for use in the awake ...
These are superior quality electrodes, fabricated from a single length of polyurethane tubing for strength and uniform smoothness. They are furnished with a specially-designed rigid stylet to facilit...
... The patented Integra Epilepsy ... advance in the design of ... connector simplifies lead tunneling and ... cable. The Flex Connector is ...
Medicine Products: